122 related articles for article (PubMed ID: 1586620)
1. A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; Clavel M; Kirkpatrick A
Ann Oncol; 1992 Mar; 3(3):223-6. PubMed ID: 1586620
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
[TBL] [Abstract][Full Text] [Related]
3. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
4. Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate.
Verweij J; Schornagel J; de Mulder P; Henzen-Logmans S; Cognetti F; Clavel M; Vermorken J
Cancer; 1990 Nov; 66(9):1910-3. PubMed ID: 2224785
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
Schornagel JH; van der Vegt S; Verweij J; de Graeff A; Dullemond-Westland A; van Deijk WA; ten Bokkel Huinink WW
Ann Oncol; 1992 Jul; 3(7):549-52. PubMed ID: 1498076
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
Pazdur R; Moore DF; Bready B; Giannone L; Maldonado A; Lin YG; Fueger RH; Winn RJ; Levin B
Ann Oncol; 1994 Sep; 5(7):646-8. PubMed ID: 7527654
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapy.
Green MD; Sherman P; Zalcberg J
Invest New Drugs; 1992 Apr; 10(1):31-4. PubMed ID: 1607252
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
Kuebler JP; Benedetti J; Schuller DE; Ensley J; Grunberg SM; Muirhead MJ; Richert-Boe KE; Marshall ME
Invest New Drugs; 1994; 12(4):341-4. PubMed ID: 7775138
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
Broun ER; Iseminger KA; Rose PG; Lentz SL; Malfetano JH; Lincoln S; Mannel R
Am J Clin Oncol; 1997 Feb; 20(1):78-80. PubMed ID: 9020294
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.
Shum KY; Kris MG; Gralla RJ; Burke MT; Marks LD; Heelan RT
J Clin Oncol; 1988 Mar; 6(3):446-50. PubMed ID: 2832548
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of 10-deazaaminopterin for advanced hypernephroma.
Scher HI; Yagoda A; Ahmed T; Hollander P; Watson RC
Anticancer Res; 1984; 4(6):409-10. PubMed ID: 6517533
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Ho AL; Lipson BL; Sherman EJ; Xiao H; Fury MG; Apollo A; Seetharamu N; Sima CS; Haque S; Lyo JK; Sales R; Cox L; Pfister DG
Invest New Drugs; 2014 Jun; 32(3):549-54. PubMed ID: 24566705
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).
Brown DH; Braakhuis BJ; Van Dongen GA; Snow GB
Otolaryngol Head Neck Surg; 1990 Jan; 102(1):20-5. PubMed ID: 2106113
[TBL] [Abstract][Full Text] [Related]
14. Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.
Pivot X; Raymond E; Laguerre B; Degardin M; Cals L; Armand JP; Lefebvre JL; Gedouin D; Ripoche V; Kayitalire L; Niyikiza C; Johnson R; Latz J; Schneider M
Br J Cancer; 2001 Sep; 85(5):649-55. PubMed ID: 11531245
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of 10-Edam in patients with advanced colorectal carcinoma.
Kemeny N; Israel K; O'Hehir M
Am J Clin Oncol; 1990 Feb; 13(1):42-4. PubMed ID: 2305719
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.
Huber MH; Dimery IW; Benner SE; Lippman SM; Shirinian M; Esparaz B; Frenning D; Guillory-Perez C; Hong WK
Invest New Drugs; 1994; 12(4):327-31. PubMed ID: 7775135
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.
Kris MG; Kinahan JJ; Gralla RJ; Fanucchi MP; Wertheim MS; O'Connell JP; Marks LD; Williams L; Farag F; Young CW
Cancer Res; 1988 Oct; 48(19):5573-9. PubMed ID: 3416310
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of 10-deaza-aminopterin in patients with advanced cancer.
Currie VE; Warrell RP; Arlin Z; Tan C; Sirotnak FM; Greene G; Young CW
Cancer Treat Rep; 1983 Feb; 67(2):149-54. PubMed ID: 6825121
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
